Company Bausch + Lomb Corporation

Equities

BLCO

CA0717051076

Medical Equipment, Supplies & Distribution

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Ratings for Bausch + Lomb Corporation

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX Other stock markets 01:21:35 2024-05-09 pm EDT			5-day change	1st Jan Change
15 ^USD	+1.32%		+7.86%	-12.37%

May. 06	Bausch + Lomb Shares Rise After Morgan Stanley Upgrade	MT
May. 06	Morgan Stanley Upgrades Bausch + Lomb to Overweight From Equalweight, Raises Price Target to $18 From $16	MT

Bausch + Lomb Corporation is a Canada-based global eye health company. The Companyâs Vision Care segment includes both a contact lens business and a consumer eye care business that consists of contact lens care products, over the counter (OTC) eye drops and eye vitamins. The Companyâs Ophthalmic Pharmaceuticals segment consists of generic pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes and retinal diseases. Its Surgical segment consists of medical device equipment, consumables, instruments and technologies for the treatment of cataracts, corneal and vitreous and retinal eye conditions, which includes delivery systems, phacoemulsification equipment and other surgical instruments and devices necessary for cataract surgery. The Companyâs brands include PreserVision, Biotrue, Artelac, Alaway, Mioclear, Ocuvite, XIIDRA, Vyzulta, Lotemax, Prolensa, Minims, and many more.

Number of employees: 13,300

USD in Million	2022	Weight	2023	Weight	Delta
Vision Care 61.3 %	2,373	63.0 %	2,543	61.3 %	+7.16%
Pharmaceuticals 20.2 %	677	18.0 %	836	20.2 %	+23.49%
Surgical 18.5 %	718	19.1 %	767	18.5 %	+6.82%

USD in Million	2022	Weight	2023	Weight	Delta
United States and Puerto Rico 46.6 %	1,695	45.0 %	1,934	46.6 %	+14.10%
Other 15.8 %	572	15.2 %	655	15.8 %	+14.51%
China 8.3 %	343	9.1 %	344	8.3 %	+0.29%
France 5.1 %	195	5.2 %	210	5.1 %	+7.69%
Japan 4.5 %	192	5.1 %	187	4.5 %	-2.60%
Germany 3.5 %	138	3.7 %	147	3.5 %	+6.52%
United Kingdom 2.9 %	108	2.9 %	121	2.9 %	+12.04%
Canada 2.7 %	101	2.7 %	110	2.7 %	+8.91%
Russia 2.6 %	132	3.5 %	106	2.6 %	-19.70%
Spain 2.1 %	77	2.0 %	85	2.1 %	+10.39%
Italy 2.0 %	72	1.9 %	82	2.0 %	+13.89%
Mexico 1.6 %	55	1.5 %	68	1.6 %	+23.64%
Poland 1.2 %	44	1.2 %	51	1.2 %	+15.91%
South Korea 1.1 %	44	1.2 %	46	1.1 %	+4.55%

Managers	Title	Age	Since
Brenton Saunders CEO	Chief Executive Officer	56	23-03-05
Sam Eldessouky DFI	Director of Finance/CFO	51	21-12-31
Yehia Hashad CTO	Chief Tech/Sci/R&D Officer	57	22-01-30
Jonathon Kellerman CMP	Compliance Officer	-	23-07-31
Alan Waterhouse COO	Chief Operating Officer	-	23-07-31
Arthur J. Shannon IRC	Investor Relations Contact	-	-
Asli Gevgilili HRO	Human Resources Officer	-	23-07-31
Dennis Asharin PRN	Corporate Officer/Principal	-	-
Seana-Lyn Carson LAW	General Counsel	51	-
Manisha A. Narasimhan PRN	Corporate Officer/Principal	48	-

Members of the board	Title	Age	Since
Brenton Saunders CEO	Chief Executive Officer	56	23-03-05
John Paulson BRD	Director/Board Member	68	-
Brett Icahn BRD	Director/Board Member	44	22-06-20
Russel Robertson BRD	Director/Board Member	76	-
Thomas Ross BRD	Director/Board Member	73	-
Andrew von Eschenbach BRD	Director/Board Member	82	-
Gary Hu BRD	Director/Board Member	36	22-06-20
Sarah Kavanagh BRD	Director/Board Member	67	-
Karen Ling BRD	Director/Board Member	60	Feb. 26
Nathalie Bernier BRD	Director/Board Member	60	21-12-31

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	351,401,653	39,215,890 ( 11.16 %)	0	11.16 %

Name	Equities	%	Valuation
BAUSCH HEALTH COMPANIES INC. 88.45 %	310,449,643	88.45 %	5 371 M $
Fidelity Investments Canada ULC 2.312 %	8,114,995	2.312 %	140 M $
GoldenTree Asset Management LP 1.344 %	4,715,829	1.344 %	82 M $
Maple Rock Capital Partners, Inc. 1.067 %	3,745,062	1.067 %	65 M $
Carl Icahn 0.9972 %	3,500,000	0.9972 %	61 M $
Citadel Securities GP LLC 0.7255 %	2,546,302	0.7255 %	44 M $
River Road Asset Management LLC 0.5379 %	1,888,065	0.5379 %	33 M $
Freshford Capital Management LLC 0.4998 %	1,754,123	0.4998 %	30 M $
Her Majesty the Queen in Right of Alberta 0.3851 %	1,351,793	0.3851 %	23 M $
NOMURA HOLDINGS, INC. 0.3579 %	1,256,181	0.3579 %	22 M $

Bausch + Lomb Corp.

520 Applewood Crescent

L4K 4B4, Vaughan

+(905) 695-7700

http://www.bausch.com

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

14.81 USD

Average target price

18.71 USD

Spread / Average Target

+26.36%

Consensus

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
BAUSCH + LOMB CORPORATION	-13.19%	5.2B
ABBOTT LABORATORIES	-4.66%	183B
MEDTRONIC PLC	-1.01%	108B
BECTON, DICKINSON AND COMPANY	-4.20%	67.51B
DEXCOM, INC.	+2.68%	50.67B
CENCORA, INC.	+9.12%	44.7B
HOYA CORPORATION	+2.41%	40.95B
WEST PHARMACEUTICAL SERVICES, INC.	+4.13%	26.71B
METTLER-TOLEDO INTERNATIONAL, INC.	+3.31%	26.8B
TERUMO CORPORATION	+12.66%	24.62B

Other Medical Equipment, Supplies & Distribution